JoinClinicalTrials.com

• In Vivo Evaluation of Growth and Risk of Rupture of Dilated Ascending Aorta Using 4D Cardiac Magnetic Resonance

  NCT03172390

  Condition:   Aortic Rupture
  Intervention:   Device: 4D Cardiac Magnetic Resonance
  Sponsor:   Centre Hospitalier Universitaire de Saint Etienne
  Recruiting
• Thoraflex Hybrid Post-Market Study

  NCT03414866

  Conditions:   Acute Aortic Dissection;   Aortic Rupture;   Penetrating Aortic Ulcer;   Aortic Dissection;   Aortic Aneurysm, Thoracic
  Intervention:   Behavioral: EQ-5D-5L QOL questionnaire
  Sponsor:   Vascutek Ltd.
  Recruiting
• Pathogenetic Basis of Aortopathy and Aortic Valve Disease

  NCT03440697

  Conditions:   Aortopathies;   Thoracic Aortic Aneurysm;   Aortic Valve Disease;   Thoracic Aortic Disease;   Thoracic Aortic Dissection;   Thoracic Aortic Rupture;   Ascending Aortic Disease;   Descending Aortic Disease;   Ascending Aortic Aneurysm;   Descending Aortic Aneurysm;   Marfan Syndrome;   Loeys-Dietz Syndrome;   Ehlers-Danlos Syndrome;   Shprintzen-Goldberg Syndrome;   Turner Syndrome;   PHACE Syndrome;   Autosomal Recessive Cutis Laxa;   Congenital Contractural Arachnodactyly;   Arterial Tortuosity Syndrome
  Intervention:  
  Sponsor:   Indiana University
  Recruiting
• Effect of Tranexamic Acid in Ruptured Abdominal Aortic Aneurysms

  NCT02125890

  Condition:   Abdominal Aortic Aneurysms
  Intervention:   Drug: Tranexamic Acid
  Sponsor:   Saskatchewan Health Authority - Regina Area
  Recruiting
• Predicting Aneurysm Growth and Rupture With Longitudinal Biomarkers

  NCT03320408

  Conditions:   Abdominal Aortic Aneurysm;   Abdominal Aortic Aneurysm, Ruptured
  Intervention:  
  Sponsors:   Ron Balm;   Parelsnoer Institute the Netherlands
  Recruiting
• Abdominal Compartment Syndrome and Ruptured Aortic Aneurysm : Validation of a Predictive Test

  NCT02859662

  Condition:   Abdominal Compartment Syndrome
  Intervention:   Procedure: ruptured aortic aneurysm
  Sponsor:   Centre Hospitalier Universitaire de Besancon
  Recruiting
• Branched Thoracic Endovascular Grafts for the Treatment of Thoraco-abdominal Aortic

  NCT01874197

  Condition:   Thoracoabdominal Aortic Aneurysm, Without Rupture
  Intervention:   Device: B-TEVAR device
  Sponsor:   University of Washington
  Recruiting
• Risk of Rupture of Aneurysms of the Thoracic Ascending Aorta (ATA) From the Dynamic Imaging

  NCT02538822

  Condition:   Aortic Aneurysm, Thoracic
  Interventions:   Device: dynamic imaging;   Device: mechanical testing
  Sponsor:   Centre Hospitalier Universitaire de Saint Etienne
  Recruiting
• Predictors of AAA Expansion and/or Rupture

  NCT03231397

  Condition:   Abdominal Aortic Aneurysm (AAA)
  Interventions:   Drug: Assess AAA rupture risk by PET-CTA scans;   Drug: 18F-fludeoxyglucose (FDG);   Diagnostic Test: 11C-PBR28
  Sponsor:   Washington University School of Medicine
  Recruiting
• EVAS2 IDE Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study

  NCT03298477

  Condition:   Abdominal Aortic Aneurysm Without Rupture
  Intervention:   Device: Nellix® System
  Sponsor:   Endologix
  Recruiting
• The British Society of Endovascular Therapy ConformabLe EndoVascular Aneurysm Repair Registry

  NCT03966521

  Condition:   Abdominal Aortic Aneurysm Without Rupture
  Intervention:  
  Sponsors:   Imperial College London;   The British Society of Endovascular Therapy (BSET)
  Recruiting
• Predicting Rupture of Abdominal Aortic Aneurysm (AAA) by Anatomic and Hemodynamic Markers From In-vivo and In-vitro Imaging.

  NCT02463760

  Condition:   Aortic Aneurysm, Abdominal
  Intervention:   Other: Medical imaging
  Sponsor:   University of Minnesota - Clinical and Translational Science Institute
  Recruiting
• Early Feasibility Study of the RelayBranch Thoracic Stent-Graft System

  NCT03214601

  Conditions:   Thoracic Aorta Aneurysm;   Aneurysm, Ruptured;   Aortic Aneurysm
  Intervention:   Device: penetrating atherosclerotic ulcer, aorta branch cardiovascular implant
  Sponsor:   Bolton Medical
  Recruiting
• Physician Modified Endovascular Grafts

  NCT01538056

  Condition:   Abdominal Aortic Aneurysms
  Intervention:   Device: Fenestrated Endovascular Graft
  Sponsor:   University of Washington
  Recruiting
• Efficacy and Safety of FP-1201-lyo (Interferon Beta-1a) in Prevention of MOF on Patients After Open Surgery for a RAAA

  NCT03119701

  Conditions:   Preventive Medicine;   Multi Organ Failure
  Interventions:   Drug: Interferon Beta-1A;   Drug: Placebo
  Sponsor:   Faron Pharmaceuticals Ltd
  Recruiting